Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...

Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss ...

Emasan AG, the investment arm of the Sandoz family, has sold a significant stake in Swiss pharmaceutical giant Novartis ...

(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.

The investment company of the Sandoz family, Emasan AG, has divested a substantial portion of its holdings in Swiss pharmaceutical giant Novartis. Through an accelerated bookbuilding process, 26.5 ...

The Sandoz Family Foundation, the second-largest shareholder in Novartis, will sell a substantial portion of its shares in the pharmaceutical giant.

The Ferrari deal is expected to be the largest of a clutch of block trades this week, including a Sfr2.6bn (€2.8bn) block in ...

The Sandoz Family Foundation, Novartis's second-largest shareholder with a 4.1% stake, has announced plans to sell a substantial portion of its holdings in the pharmaceutical giant. This strategic ...

European stocks advanced to a record high as a slate of corporate earnings boosted sentiment, while investors monitored ...

Tesla is readying a software update for customers in China to offer driving-assistance capabilities similar to its full ...

The European stock markets closed higher in Wednesday trading as The Stoxx Europe 600 rose 0.99%, Germany's DAX climbed 1.73%, the FTSE 100 in London gained 0.72%, France's CAC 40 advanced 1.15%, and ...